Textbook/Part 7/Chapter 20

Future Directions in Vascular Surgery

Emerging technologies, AI applications, and future directions in vascular surgery

13 sections
33 references
Last updated today

Background

Vascular surgery has undergone a profound transformation in the past three decades, shifting from exclusively open procedures to endovascular and hybrid approaches [1]. This evolution continues, driven by technological advances, big data [2], artificial intelligence (AI), and changing healthcare systems.

The "vascular surgeon of the future" will need to master open, endovascular, and hybrid techniques, understand new biomaterials and devices, and incorporate AI-based decision support, registries [2], and simulation into daily practice.

Endovascular Expansion

  • EVAR, TEVAR, FEVAR, BEVAR [3], PMEG [4] now standard for most aneurysms [5] (see 4Aneurysms and 6Thoracic Aortic).
  • Complex aortic repairs increasingly endovascular, with open reserved for select cases [6].
  • SFA and iliac interventions dominated by drug-coated balloons (DCB) [7], drug-eluting stents (DES) [8], and bioresorbable scaffolds (see 10PAD) [9].

Hybrid Surgery

  • Hybrid operating rooms allow simultaneous open and endovascular procedures [10].
  • Examples: carotid stenting with open access [11] (see 7Carotid/7Carotid), iliac conduits for EVAR, hybrid trauma (laparotomy + embolization [12], see 16EVTM) [13].

Multidisciplinary Care

  • Vascular surgery overlaps with cardiology, radiology, nephrology, oncology.
  • Heart-team and vascular-team models [14] becoming standard [15].

Personalized Medicine

  • Molecular profiling (e.g., AAA rupture risk, venous thrombosis genetics) [16].
  • Targeted antithrombotic therapy [17] [18].
  • 3D printing for patient-specific device planning.

Artificial Intelligence (AI) and Big Data

  • AI-based imaging analysis: automatic plaque morphology, aneurysm growth prediction, vessel sizing [19].
  • Machine learning registries: Swedvasc [20], Vascunet [2] [21], EVTM Registry [22].
  • Clinical decision support systems: real-time guidance in the hybrid OR [19].

Robotics and Automation

  • Robotic catheter navigation (Magellan, Corindus) → reduced radiation exposure [23].
  • Robotic assistance in open/endovascular surgery under development [23].

Advanced Biomaterials

  • Drug-eluting [8] and bioresorbable stents.
  • Next-generation covered stents with reduced thrombosis risk [24].
  • Endovascular grafts with branched/fenestrated designs [3] increasingly customizable.

Regenerative and Molecular Therapies

  • Stem-cell therapies for critical limb ischemia (CLI).
  • Gene therapy for arteriogenesis and angiogenesis.
  • Targeted anti-inflammatory therapies in AAA [25] and atherosclerosis [26].

Wearables and Remote Monitoring

  • Smart compression garments with pressure sensors.
  • Telemedicine for wound/ulcer care follow-up.
  • Continuous BP and perfusion monitoring in vascular patients.

Education and Simulation

  • Virtual reality (VR) and augmented reality (AR) for training and intraoperative guidance.
  • 3D printed models for preoperative rehearsal (complex EVAR, FEVAR, trauma).
  • AI-driven simulators for continuous skill assessment.

Global and Societal Aspects

  • Aging population: vascular disease burden increasing worldwide [27].
  • Global disparities: limited access to endovascular technology in LMICs (low- and middle-income countries) [28].
  • Sustainability: device reuse, cost-effective strategies, minimizing carbon footprint of vascular surgery.

Future Paradigms

  • Total endovascular aortic surgery as default [29].
  • 16EVTM fully integrated into trauma care worldwide [13] [30].
  • Hybrid vascular surgeon (open + endovascular + AI skills) as the new standard [1].
  • Predictive vascular medicine using AI + genomics [19].
  • Expanded use of minimally invasive devices even in emergency/field conditions [31] [30].

References

  1. Patel VI, et al. Evolution of vascular surgery into an endovascular specialty. J Vasc Surg. 2017. PubMed
  2. Powell JT, et al. Endovascular vs open repair of 4Aneurysms – long-term results. NEJM. 2010. PubMed [32]
  3. Wanhainen A, et al. ESVS Guidelines on 4Aneurysms. Eur J Vasc Endovasc Surg. 2019. PubMed [29]
  4. Björck M, et al. ESVS 2025 Guidelines on Mesenteric and Renal Arteries. Eur J Vasc Endovasc Surg. 2025. PubMed [33]
  5. Hörer TM, et al. 16EVTM paradigm in trauma and resuscitation. J Trauma Acute Care Surg. 2016. PubMed [13]
  6. Mouawad NJ, et al. The role of robotics in vascular surgery. Vascular. 2020. PubMed [23]
  7. Conte MS, et al. Global vascular guidelines on chronic limb-threatening ischemia. J Vasc Surg. 2019. PubMed [14]
  8. Mani K, et al. The role of registries in vascular surgery (Swedvasc, Vascunet). Eur J Vasc Endovasc Surg. 2020. PubMed [2]
  9. Daye D, Walker TG. Novel endovascular devices for peripheral interventions. Tech Vasc Interv Radiol. 2018. PubMed [24]
  10. Loftus IM, et al. Future challenges in vascular surgery: global and societal perspectives. Br J Surg. 2021. PubMed

References

  1. [1]
    Mani K, et al. The role of registries in vascular surgery (Swedvasc, Vascunet). *Eur J Vasc Endovasc Surg*. 2020. PubMedPMID: 25282512
  2. [2]
    Mills JL Sr. Vascular surgery training in the United States: a half-century of evolution. *J Vasc Surg*. 2008;48(6 Suppl):90S-97S. PubMedPMID: 19084755
  3. [3]
    Dake MD, et al. Zilver PTX trial: drug-eluting stent. *NEJM*. 2011;364:1873–83. PubMed. DES for PAD.PMID: 21953370
  4. [4]
    Erbel R, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J. 2014;35(41):2873-2926.PMID: 25173340
  5. [5]
    Aboyans V, Ricco JB, Bartelink M-LEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763-816.PMID: 28886620
  6. [6]
    Wanhainen A, et al. ESVS Guidelines on AAA. *Eur J Vasc Endovasc Surg*. 2019. PubMedPMID: 30947488
  7. [7]
    Katsargyris A, et al. PMEG for complex AAA. *J Vasc Surg*. 2017. PubMedPMID: 27374063
  8. [8]
    Oderich GS, et al. BEVAR outcomes. *J Vasc Surg*. 2017. PubMedPMID: 28596039
  9. [9]
    Tepe G, et al. IN.PACT SFA trial: drug-coated balloon. *Circulation*. 2015;131:495–502. PubMed. Endovascular therapy.PMID: 25472980
  10. [10]
    Bisdas T, et al. Hybrid revascularization strategies. *J Vasc Surg*. 2013;57:116–23. PubMed. Hybrid therapy.PMID: 20488323
  11. [11]
    Coccolini F, et al. WSES guidelines on pelvic trauma: bleeding control and embolization. *World J Emerg Surg*. 2017. PubMedPMID: 28115984
  12. [12]
    Hörer TM, et al. EVTM paradigm in trauma and resuscitation. *J Trauma Acute Care Surg*. 2016. PubMedPMID: 27709280
  13. [13]
    Malas MB, et al. ROADSTER trial (TCAR). *J Vasc Surg*. 2019. PubMedPMID: 30611582
  14. [14]
    Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6S):3S-125S.e40.PMID: 31159978
  15. [15]
    Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165.PMID: 30165437
  16. [16]
    Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med. 2017;377:1319-1330.PMID: 28844192
  17. [17]
    Sakalihasan N, Michel JB, et al. Abdominal aortic aneurysms. *Nat Rev Cardiol*. 2018;15:225–37. PubMed. AAA biology.PMID: 30337540
  18. [18]
    Bonaca MP, Bauersachs RM, Anand SS, Debus ES, et al. Rivaroxaban in Peripheral Artery Disease after Revascularization. N Engl J Med. 2020;382:1994-2004.PMID: 32187464
  19. [19]
    van Engelen A, et al. AI in PAD imaging. *Eur Heart J*. 2020. PubMedPMID: 32007997
  20. [20]
    EVTM Registry Collaboration. Global EVTM registry data. *JEVTM*. 2020. JEVTMLink
  21. [21]
    Swedvasc Annual Report 2022. National vascular registry, Sweden. Link. Registry outcomes.Link
  22. [22]
    Vascunet Collaboration. International vascular surgery outcomes. *Eur J Vasc Endovasc Surg*. 2019;58:345–54. PubMed. Registry data.PMID: 31235415
  23. [23]
    Mouawad NJ, et al. The role of robotics in vascular surgery. *Vascular*. 2020. PubMedPMID: 30526364
  24. [24]
    Daye D, Walker TG. Novel endovascular devices for peripheral interventions. *Tech Vasc Interv Radiol*. 2018. PubMedPMID: 29784139
  25. [25]
    Golledge J, et al. Medical therapies to limit AAA growth. *Lancet Diabetes Endocrinol*. 2017;5:185–93. PubMed. AAA medical management.PMID: 27641464
  26. [26]
    Libby P. The changing landscape of atherosclerosis. *Nature*. 2021;592:524–33. PubMed. Mechanistic insights.PMID: 33883728
  27. [27]
    Bencheikh N, Zarrintan S, Quatramoni JG, et al. Vascular Surgery in Low-Income and Middle-Income Countries: A State-of-the-Art Review. *Ann Vasc Surg*. 2023;95:297-306. PubMedPMID: 37285965
  28. [28]
    GBD 2019 Vascular Disease Collaborators. Global burden of vascular disease. *Lancet*. 2020. PubMed. Global epidemiology.PMID: 32326912
  29. [29]
    Bulger EM, Perina DG, Qasim ZA, et al. Clinical use of REBOA in civilian trauma systems: ACS-COT/NAEMSP joint statement. Trauma Surg Acute Care Open. 2019;4:e000376.PMID: 31559211
  30. [30]
    Koelemay MJW, Iborra E, Malan A, et al. ESVS 2025 Guidelines on Diseases of the Mesenteric and Renal Arteries and Veins. *Eur J Vasc Endovasc Surg*. 2025. PubMed PubMedPMID: 40513642
  31. [31]
    Morrison JJ, et al. Resuscitative endovascular balloon occlusion of the aorta (REBOA): a bridge to definitive hemorrhage control. *Ann Surg*. 2014. PubMedPMID: 25133599
  32. [32]
    Powell JT, et al. Endovascular vs open repair of AAA – long-term results. *NEJM*. 2010. PubMedPMID: 20395842
  33. [33]
    Wanhainen A, Verzini F, Van Herzeele I, et al. Editor's Choice – ESVS 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms. Eur J Vasc Endovasc Surg. 2019;57(1):8–93.PMID: 30528142

Educational use only

This content is NOT intended as clinical decision support.

All content traces to PubMed, ESVS/SVS guidelines, or Rutherford's textbook.